# Budesonide/Formoterol Turbuhaler® Versus Terbutaline Nebulization as Reliever Therapy in Children With Moderate Asthma Exacerbation

> **NCT04705727** · PHASE3 · TERMINATED · sponsor: **Centre Hospitalier Intercommunal Creteil** · enrollment: 102 (actual)

## Conditions studied

- Asthma in Children

## Interventions

- **DRUG:** Budesonide Formoterol Drug Combination
- **DRUG:** nebulisation of terbutaline

## Key facts

- **NCT ID:** NCT04705727
- **Lead sponsor:** Centre Hospitalier Intercommunal Creteil
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-08-23
- **Primary completion:** 2021-09-23
- **Final completion:** 2023-06-23
- **Target enrollment:** 102 (ACTUAL)
- **Why stopped:** Not enough recruitment in th trial
- **Last updated:** 2023-07-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04705727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04705727, "Budesonide/Formoterol Turbuhaler® Versus Terbutaline Nebulization as Reliever Therapy in Children With Moderate Asthma Exacerbation". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT04705727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*